> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Drug/Biologic IND Safety Reporting
- URL: https://www.fdaweb.com/comments-sought-on-drug-biologic-ind-safety-reporting/
- Published: 2016-03-18T12:00:00.000Z
- Updated: 2026-09-15T02:45:07.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135131

*Federal Register* Notice: FDA seeks comment on “Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans.” Comments should be submitted by 5/17\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-03-18/pdf/2016-06128.pdf?ref=fdaweb.com)